Medical Cannabis
- Generic Name
- Medical Cannabis
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- FTS5RM302N
- Background
The use of the plant species Cannabis sativa and Cannabis indica, popularly known as marijuana, has gained popularity in recent years for the management of a wide variety of medical conditions as a wave of legalization in North America has changed public and medical opinion on its use. Consequently, an expanding body of evidence has begun to emerge that has ...
- Associated Conditions
- -
- Associated Therapies
- -
Vaped Marijuana to Attenuate Naloxone-Precipitated Withdrawal
- First Posted Date
- 2021-11-10
- Last Posted Date
- 2024-12-19
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 2
- Registration Number
- NCT05114460
- Locations
- 🇺🇸
New York State Psychiatric Institute, New York, New York, United States
Effect of Medical Cannabis for Non-motor Symptoms of Parkinson's Disease
- Conditions
- Interventions
- First Posted Date
- 2021-11-03
- Last Posted Date
- 2021-11-03
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 100
- Registration Number
- NCT05106504
- Locations
- 🇮🇱
Sheba Medical Center, Ramat-Gan, Israel
Exploring Medically Perceived Benefits, Use and Interest in Psychedelics and Cannabinoids
- First Posted Date
- 2021-07-16
- Last Posted Date
- 2022-08-12
- Lead Sponsor
- Empower Research Inc
- Target Recruit Count
- 102
- Registration Number
- NCT04965740
- Locations
- 🇨🇦
Centre for Neurology Studies, Surrey, British Columbia, Canada
The Impact of Oral Cannabis Administration and Co-Administration of Alcohol on Impairment
- Conditions
- Interventions
- First Posted Date
- 2021-06-18
- Last Posted Date
- 2024-03-19
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 90
- Registration Number
- NCT04931095
- Locations
- 🇺🇸
Johns Hopkins Behavioral Pharmacology Research Unit, Baltimore, Maryland, United States
Cannabis Inhalation: Effects on Cardiovascular Function During Rest and Exercise
- Conditions
- Interventions
- First Posted Date
- 2021-01-05
- Last Posted Date
- 2023-11-28
- Lead Sponsor
- Jamie Burr
- Target Recruit Count
- 20
- Registration Number
- NCT04693884
- Locations
- 🇨🇦
University of Guelph, Guelph, Ontario, Canada
Impact of Repeatedly-Administered THC-cannabis on Experimental Pain and Abuse Liability in Humans
- First Posted Date
- 2020-10-22
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 16
- Registration Number
- NCT04596644
- Locations
- 🇺🇸
New York State Psychiatric Institute, New York, New York, United States
Repeated Cannabis Administration on Experimental Pain and Abuse Liability
- First Posted Date
- 2020-10-06
- Last Posted Date
- 2024-05-24
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 16
- Registration Number
- NCT04576507
- Locations
- 🇺🇸
New York State Psychiatric Institute, New York, New York, United States
The Kinetics of Endocannabinoids in Patients With Chemotherapy Induced Peripheral Neuropathy by Using Medical Cannabis.
- Conditions
- Interventions
- First Posted Date
- 2020-05-06
- Last Posted Date
- 2022-03-16
- Lead Sponsor
- HaEmek Medical Center, Israel
- Target Recruit Count
- 40
- Registration Number
- NCT04376437
- Locations
- 🇮🇱
Haemek MC, Afula, North, Israel
Age Differences in the Effects of Cannabis on Simulated Driving
- First Posted Date
- 2020-03-30
- Last Posted Date
- 2024-04-29
- Lead Sponsor
- Centre for Addiction and Mental Health
- Target Recruit Count
- 128
- Registration Number
- NCT04325958
- Locations
- 🇨🇦
Centre for Addiction and Mental Health, Toronto, Ontario, Canada
Behavioral Pharmacology of Cannabis and Nicotine
- First Posted Date
- 2019-10-11
- Last Posted Date
- 2024-04-17
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 26
- Registration Number
- NCT04124432
- Locations
- 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.